Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 25Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Aspen Pharmacare Holdings

02 3Actavis Inc

03 5Adcock Ingram

04 1Ascot Pharma

05 3Bausch & Lomb Incorporated

06 1Bayshore Pharmaceuticals

07 1Bio Labs

08 1ECUPHARMA Srl

09 2Galt Pharmaceuticals

10 1Hikma Pharmaceuticals

11 3Jerome Stevens Pharmaceuticals

12 1Lupin Ltd

13 1Meda AB

14 1PAI Pharmaceutical Associates

15 1Prizam Alliance

16 2Rising Pharmaceuticals Inc

17 1Sagent Pharmaceuticals

18 7Sandoz B2B

19 5iNova Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
American Pharma Summit
Not Confirmed

Orphenadrine Citrate

Brand Name : Lenaspasm

Dosage Form : TAB

Dosage Strength : 35mg

Packaging : 24X1mg

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

Aspen API Comapny Banner

02

arrow
American Pharma Summit
Not Confirmed

Orphenadrine Citrate

Brand Name : Lenaspasm

Dosage Form : TAB

Dosage Strength : 35mg

Packaging : 48X1mg

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

Aspen API Comapny Banner

03

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ORPHENADRINE CITRATE

Brand Name : NORFLEX

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1982-01-01

Application Number : 12157

Regulatory Info : DISCN

Registration Country : USA

blank

04

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Brand Name : NORGESIC

Dosage Form : TABLET;ORAL

Dosage Strength : 385MG;30MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1982-10-27

Application Number : 13416

Regulatory Info : DISCN

Registration Country : USA

blank

05

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Brand Name : NORGESIC FORTE

Dosage Form : TABLET;ORAL

Dosage Strength : 770MG;60MG;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1982-10-27

Application Number : 13416

Regulatory Info : DISCN

Registration Country : USA

blank

06

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Brand Name : ORPHENGESIC

Dosage Form : TABLET;ORAL

Dosage Strength : 385MG;30MG;25MG

Packaging :

Approval Date : 1998-05-29

Application Number : 75141

Regulatory Info : RX

Registration Country : USA

blank

07

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Brand Name : ORPHENGESIC FORTE

Dosage Form : TABLET;ORAL

Dosage Strength : 770MG;60MG;50MG

Packaging :

Approval Date : 1998-05-29

Application Number : 75141

Regulatory Info : RX

Registration Country : USA

blank

08

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ORPHENADRINE CITRATE

Brand Name : ORPHENADRINE CITRATE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 30MG/ML

Packaging :

Approval Date : 2003-03-04

Application Number : 40463

Regulatory Info : RX

Registration Country : USA

blank

09

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ORPHENADRINE CITRATE

Brand Name : ORPHENADRINE CITRATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 100MG

Packaging :

Approval Date : 2000-06-23

Application Number : 40368

Regulatory Info : DISCN

Registration Country : USA

blank

10

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Brand Name : ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE

Dosage Form : TABLET;ORAL

Dosage Strength : 385MG;30MG;25MG

Packaging :

Approval Date : 1999-04-30

Application Number : 74988

Regulatory Info : DISCN

Registration Country : USA

blank

11

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Brand Name : ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE

Dosage Form : TABLET;ORAL

Dosage Strength : 770MG;60MG;50MG

Packaging :

Approval Date : 1999-04-30

Application Number : 74988

Regulatory Info : DISCN

Registration Country : USA

blank

12

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ORPHENADRINE CITRATE

Brand Name : ORPHENADRINE CITRATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 100MG

Packaging :

Approval Date : 1998-06-19

Application Number : 40284

Regulatory Info : RX

Registration Country : USA

blank

13

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ORPHENADRINE CITRATE

Brand Name : NORFLEX

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 30MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1982-01-01

Application Number : 13055

Regulatory Info : DISCN

Registration Country : USA

blank

14

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ORPHENADRINE CITRATE

Brand Name : ORPHENADRINE CITRATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 100MG

Packaging :

Approval Date : 1999-01-29

Application Number : 40249

Regulatory Info : RX

Registration Country : USA

blank

15

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ORPHENADRINE CITRATE

Brand Name : ORPHENADRINE CITRATE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 30MG/ML

Packaging :

Approval Date : 2006-05-24

Application Number : 40484

Regulatory Info : RX

Registration Country : USA

blank

16

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ORPHENADRINE CITRATE

Brand Name : ORPHENADRINE CITRATE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 100MG

Packaging :

Approval Date : 2000-02-15

Application Number : 40327

Regulatory Info : RX

Registration Country : USA

blank

17

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Brand Name : ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE

Dosage Form : TABLET;ORAL

Dosage Strength : 385MG;30MG;25MG

Packaging :

Approval Date : 1996-12-31

Application Number : 74654

Regulatory Info : DISCN

Registration Country : USA

blank

18

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Brand Name : ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE

Dosage Form : TABLET;ORAL

Dosage Strength : 770MG;60MG;50MG

Packaging :

Approval Date : 1996-12-31

Application Number : 74654

Regulatory Info : DISCN

Registration Country : USA

blank

19

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Brand Name : INVAGESIC

Dosage Form : TABLET;ORAL

Dosage Strength : 385MG;30MG;25MG

Packaging :

Approval Date : 1996-11-27

Application Number : 74817

Regulatory Info : DISCN

Registration Country : USA

blank

20

American Pharma Summit
Not Confirmed
arrow
arrow
American Pharma Summit
Not Confirmed

ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Brand Name : INVAGESIC FORTE

Dosage Form : TABLET;ORAL

Dosage Strength : 770MG;60MG;50MG

Packaging :

Approval Date : 1996-11-27

Application Number : 74817

Regulatory Info : DISCN

Registration Country : USA

blank